Impact of the mutation A21G (Flemish Variant) on Alzheimer's β-amyloid dimers by molecular dynamics simulations

Biophysical Journal

Volumn 91, Issue 10, 2006, Pages 3829-3840

  Huet, Alexis ^a   Derreumaux, Philippe ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; DIMER;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; GENE MUTATION; HUMAN; IN VITRO STUDY; MOLECULAR DYNAMICS; POINT MUTATION; PROTEIN CONFORMATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; PROTEIN VARIANT; SIMULATION;

EID: 33751218920     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.106.090993     Document Type: Article

References (56)

1. Dobson, C. M. 2003. Protein folding and misfolding. Nature. 426:884-890.
2. Kang, J., H. G. Lemaire, A. Unterbeck, J. M. Salbaum, C. L. Masters, K. H. Grzeschik, G. Multhaup, K. Beyreuther, and B. Muller-Hill. 1987. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:733-736.
3. Nelson, R., M. R. Sawaya, M. Balbirnie, A. Madsen, C. Riekel, R. Grothe, and D. Eisenberg. 2005. Structure of the cross-β spine of amyloid-like fibrils. Nature. 435:773-778.
4. Petkova, A. T., Y. Ishii, J. J. Balbach, O. N. Antzutkin, R. D. Leapman, F. Delaglio, and R. Tycko. 2002. A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. USA. 99:16742-16747.
5. Petkova, A. T., W.-M. Yau, and R. Tycko. 2006. Experimental constraints on quaternary structure in Alzheimer's β-amyloid fibrils. Biochemistry. 45:498-512.
6. Luhrs, T., C. Ritter, M. Adrian, D. Riek-Loher, B. Bohrmann, H. Dobeli, D. Schubert, and R. Riek. 2005. 3D structure of Alzheimer's amyloid-β(1-42) fibrils. Proc. Natl. Acad. Sci. USA. 102:17342-17347.
7. Olofsson, A., A. E. Sauer-Eriksson, and A. Ohman. 2006. The solvent protection of Alzheimer amyloid-β-(1-42) fibrils as determined by solution NMR spectroscopy. J. Biol. Chem. 281:477-483.
8. Williams, A. D., S. Shivaprasad, and R. Wetzel. 2006. Alanine scanning mutagenesis of Aβ (1-40) amyloid fibril stability. J. Mol. Biol. 357:1283-1294.
9. Morimoto, A., K. Irie, K. Murakami, Y. Masuda, H. Ohigashi, M. Nagao, H. Fukuda, T. Shimizu, and T. Shirasawa. 2004. Analysis of the secondary structure of β-amyloid (Aβ-42) fibrils by systematic proline replacement. J. Biol. Chem. 279:52781-52788.
10. Bitan, G., M. D. Kirkitadze, A. Lomakin, S. S. Vollers, G. B. Benedek, and D. B. Teplow. 2003. Amyloid β-protein (Aβ) assembly: Aβ-40 and Aβ-42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. USA. 100:330-335.
11. Hendriks, L., C. M. van Duijn, P. Cras, M. Cruts, W. V. Hul, F. van Harskamp, A. Warren, M. G. McInnis, S. E. Antonarakis, and J. J. Martin. 1992. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene. Nat. Genet. 1:218-221.
12. Levy, E., M. D. Carman, I. J. Fernandez-Madrid, M. D. Power, I. Lieberburg, S. G. van Duinen, G. T. Bots, W. Luyendijk, and B. Frangione. 1990. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science. 248:1124-1126.
13. Broeckhoven, C. V., J. Haan, E. Bakker, J. A. Hardy, W. V. Hul, A. Wehnert, M. V.-V. der Vlis, and R. A. Roos. 1990. Amyloid β-protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science. 248:1120-1122.
14. Rossi, G., G. Macchi, M. Porro, G. Giaccone, M. Bugiani, E. Scarpini, G. Scarlato, G. E. Molini, F. Sasanelli, O. Bugiani, and F. Tagliavini. 1998. Fatal familial insomnia: genetic, neuropathologic, and biochemical study of a patient from a new Italian kindred. Neurology. 50:688-692.
15. Nilsberth, C., A. Westlind-Danielsson, C. B. Eckman, M. M. Condron, K. Axelman, C. Forsell, C. Stenh, J. Luthman, D. B. Teplow, S. G. Younkin, J. Naslund, and L. Lannfelt. 2001. The "Arctic" APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation. Nat. Neurosci. 4:887-893.
16. Grabowski, T. J., H. S. Cho, J. P. Vonsattel, G. W. Rebeck, and S. M. Greenberg. 2001. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann. Neurol. 49:697-705.
17. Murakami, K., K. Irie, A. Morimoto, H. Ohigashi, M. Shindo, M. Nagao, T. Shimizu, and T. Shirasawa. 2002. Synthesis, aggregation, neurotoxicity, and secondary structure of various A β 1-42 mutants of familial Alzheimer's disease at positions 21-23. Biochem. Biophys. Res. Commun. 294:5-10.
18. Murakami, K., K. Irie, A. Morimoto, H. Ohigashi, M. Shindo, M. Nagao, T. Shimizu, and T. Shirasawa. 2003. Neurotoxicity and physicochemical properties of Aβ mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease. J. Biol. Chem. 278:46179-46187.
19. Roher, A. E., M. O. Chaney, Y. M. Kuo, S. D. Webster, W. B. Stine, L. J. Haverkamp, A. S. Woods, R. J. Cotter, J. M. Tuohy, G. A. Krafft, B. S. Bonnell, and M. R. Emmerling. 1996. Morphology and toxicity of Aβ-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J. Biol. Chem. 271:20631-20635.
20. Cleary, J. P., D. M. Walsh, J. J. Hofmeister, G. M. Shankar, M. A. Kuskowski, D. J. Selkoe, and K. H. Ashe. 2005. Natural oligomers of the amyloid-β protein specifically disrupt cognitive function. Nat. Neurosci. 8:79-84.
21. Soreghan, B., J. Kosmoski, and C. Glabe. 1994. Surfactant properties of Alzheimer's Aβ peptides and the mechanism of amyloid aggregation. J. Biol. Chem. 269:28551-28554.
22. Garzon-Rodriguez, W., M. Sepulveda-Becerra, S. Milton, and C. G. Glabe. 1997. Soluble amyloid Aβ-(1-40) exists as a stable dimer at low concentrations. J. Biol. Chem. 272:21037-21044.
23. Garzon-Rodriguez, W., A. Vega, M. Sepulveda-Becerra, S. Milton, D. A. Johnson, A. K. Yatsimirsky, and C. G. Glabe. 2000. A conformation change in the carboxyl terminus of Alzheimer's Aβ (1-40) accompanies the transition from dimer to fibril as revealed by fluorescence quenching analysis. J. Biol. Chem. 275:22645-22649.
24. Tarus, B., J. E. Straub, and D. Thirumalai. 2005. Probing the initial stage of aggregation of the Aβ (10-35)-protein: assessing the propensity for peptide dimerization. J. Mol. Biol. 345:1141-1156.
25. Tao Guo, J., R. Wetzel, and Y. Xu. 2004. Molecular modeling of the core of Aβ amyloid fibrils. Proteins. 57:357-364.
26. Ma, B., and R. Nussinov. 2002. Stabilities and conformations of Alzheimer's β-amyloid peptide oligomers (Aβ 16-22, Aβ 16-35, and Aβ 10-35): sequence effects. Proc. Natl. Acad. Sci. USA. 99:14126-14131.
27. Buchete, N.-V., R. Tycko, and G. Hummer. 2005. Molecular dynamics simulations of Alzheimer's β-amyloid protofilaments. J. Mol. Biol. 353:804-821.
28. Urbanc, B., L. Cruz, F. Ding, D. Sammond, S. Khare, S. V. Buldyrev, H. E. Stanley, and N. V. Dokholyan. 2004. Molecular dynamics simulation of amyloid β-dimer formation. Biophys. J. 87:2310-2321.
29. Urbanc, B., L. Cruz, S. Yun, S. V. Buldyrev, G. Bitan, D. B. Teplow, and H. E. Stanley. 2004. In silico study of amyloid β-protein folding and oligomerization. Proc. Natl. Acad. Sci. USA. 101:17345-17350.
30. Paravastu, A. K., A. T. Petkova, and R. Tycko. 2006. Polymorphic fibril formation by residues 10-40 of the Alzheimer's β-amyloid peptide. Biophys. J.
31. Lazo, N. D., M. A. Grant, M. C. Condron, A. C. Rigby, and D. B. Teplow. 2005. On the nucleation of amyloid β-protein monomer folding. Protein Sci. 14:1581-1596.
32. Borreguero, J. M., B. Urbanc, N. D. Lazo, S. V. Buldyrev, D. B. Teplow, and H. E. Stanley. 2005. Folding events in the 21-30 region of amyloid β-protein (Aβ) studied in silico. Proc. Natl. Acad. Sci. USA. 102:6015-6020.
33. Petkova, A. T., R. D. Leapman, Z. Guo, W.-M. Yau, M. P. Mattson, and R. Tycko. 2005. Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils. Science. 307:262-265.
34. Spoel, D. V. D., E. Lindahl, B. Hess, G. Groenhof, A. E. Mark, and H. J. C. Berendsen. 2005. GROMACS: fast, flexible, and free. J. Comput. Chem. 26:1701-1718.
35. Guex, N., and M. C. Peitsch. 1997. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis. 18:2714-2723.
36. Walser, R., A. E. Mark, and W. F. van Gunsteren. 2000. On the temperature and pressure dependence of a range of properties of a type of water model commonly used in high-temperature protein unfolding simulations. Biophys. J. 78:2752-2760.
37. Dinner, A. R., and M. Karplus. 1999. Is protein unfolding the reverse of protein folding? A lattice simulation analysis. J. Mol. Biol. 292:403-419.
38. Klimov, D. K., and D. Thirumalai. 2005. Symmetric connectivity of secondary structure elements enhances the diversity of folding pathways. J. Mol. Biol. 353:1171-1186.
39. Frishman, D., and P. Argos. 1995. Knowledge-based protein secondary structure assignment. Proteins. 23:566-579.
40. Day, R., B. J. Bennion, S. Ham, and V. Daggett. 2002. Increasing temperature accelerates protein unfolding without changing the pathway of unfolding. J. Mol. Biol. 322:189-203.
41. Humphrey, W., A. Dalke, and K. Schulten. 1996. VMD: visual molecular dynamics. J. Mol. Graph. 14:27-38.
42. Dima, R. I., and D. Thirumalai. 2002. Exploring protein aggregation and self-propagation using lattice models: phase diagram and kinetics. Protein Sci. 11:1036-1049.
43. Santini, S., G. Wei, N. Mousseau, and P. Derreumaux. 2004. Pathway complexity of Alzheimer's β-amyloid Aβ-16-22 peptide assembly. Structure. 12:1245-1255.
44. Lee, B., and F. M. Richards. 1971. The interpretation of protein structures: estimation of static accessibility. J. Mol. Biol. 55:379-400.
45. Ghosh, T., S. Garde, and A. E. Garcia. 2003. Role of backbone hydration and salt-bridge formation in stability of α-helix in solution. Biophys. J. 85:3187-3193.
46. Gilbert, D., D. Westhead, N. Nagano, and J. Thornton. 1999. Motif-based searching in TOPS protein topology databases. Bioinformatics. 15:317-326.
47. Zhang, S., K. Iwata, M. J. Lachenmann, J. W. Peng, S. Li, E. R. Stimson, Y. Lu, A. M. Felix, J. E. Maggio, and J. P. Lee. 2000. The Alzheimer's peptide Aβ adopts a collapsed coil structure in water. J. Struct. Biol. 130:130-141.
48. 35 oxidation state affects the mechanism of amyloid formation. J. Am. Chem. Soc. 126:1992-2005.
49. Massi, F., J. W. Peng, J. P. Lee, and J. E. Straub. 2001. Simulation study of the structure and dynamics of the Alzheimer's amyloid peptide congener in solution. Biophys. J. 80:31-44.
50. Narayanan, S., and B. Reif. 2005. Characterization of chemical exchange between soluble and aggregated states of β-amyloid by solution-state NMR upon variation of salt conditions. Biochemistry. 44:1444-1452.
51. Flock, D., S. Colacino, G. Colombo, and A. D. Nola. 2006. Misfolding of the amyloid β-protein: a molecular dynamics study. Proteins. 62:183-192.
52. Sciarretta, K. L., D. J. Gordon, A. T. Petkova, R. Tycko, and S. C. Meredith. 2005. Aβ40-Lactam(D23/K28) models a conformation highly favorable for nucleation of amyloid. Biochemistry. 44:6003-6014.
53. Bitan, G., S. S. Vollers, and D. B. Teplow. 2003. Elucidation of primary structure elements controlling early amyloid β-protein oligomerization. J. Biol. Chem. 278:34882-34889.
54. Huang, T. H., D. S. Yang, N. P. Plaskos, S. Go, C. M. Yip, P. E. Fraser, and A. Chakrabartty. 2000. Structural studies of soluble oligomers of the Alzheimer β-amyloid peptide. J. Mol. Biol. 297:73-87.
55. Walsh, D. M., D. M. Hartley, Y. Kusumoto, Y. Fezoui, M. M. Condron, A. Lomakin, G. B. Benedek, D. J. Selkoe, and D. B. Teplow. 1999. Amyloid β-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274:25945-25952.
56. Kirkitadze, M. D., M. M. Condron, and D. B. Teplow. 2001. Identification and characterization of key kinetic intermediates in amyloid β-protein fibrillogenesis. J. Mol. Biol. 312:1103-1119.